Clinical Trial

Evaluation of the Care Provided to Patients Who Underwent Bariatric Surgery and Were Lost to Follow-up 5 Years After Surgery

Study acronym: OBEPER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated October 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
In 2025, bariatric surgery combined with nutritional and psychological support is one of the most effective treatments for patients with morbid obesity. (2)(3) However, it causes various deficiencies, such as vitamin and iron deficiencies, which justify lifelong personalised vitamin supplementation and, consequently, lifelong medical supervision. The latest recommendations from the French National Authority for Health (Haute Autorité de Santé) clearly state that patients must commit to lifelong medical follow-up after bariatric surgery. (HAS, February 2024, R94). R94. Regular biological monitoring after bariatric surgery is recommended: three times in the first year and then once or twice a year thereafter. Within the OBESEPI cohort (clinical trial number NCT02663388), which comprises patients who underwent surgery at Nancy University Hospital between 2013 and 2018, we observed that over 50% of patients were lost to follow-up five years after surgery.
Trial Details
NCT Number NCT07118540
Lead Sponsor Central Hospital, Nancy, France
Conditions Obesity & Overweight
Enrollment 176 participants
Start Date 2025-06-01
Primary Completion 2025-10-10 (estimated)
Study Completion 2025-10-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-12